Ultrasonographic subclinical signs of inflammation of the lacrimal, parotid, and submandibular glands in users of cosmetic fillers
dc.contributor.author | Wortsman, Ximena | |
dc.contributor.author | Moll-Manzur, Catherina | |
dc.contributor.author | Ramirez-Cornejo, Cristian | |
dc.contributor.author | Alfaro-Sepulveda, Daniela | |
dc.contributor.author | Mellado-Francisco, Gonzalo | |
dc.contributor.author | Rezende, Juliana | |
dc.contributor.author | Vera-Kellet, Cristian | |
dc.date.accessioned | 2025-01-20T23:55:23Z | |
dc.date.available | 2025-01-20T23:55:23Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objectives To detect ultrasonographic inflammatory signs in the lacrimal, parotid, and submandibular glands in cosmetic fillers (CFs) users. | |
dc.description.abstract | Methods A prospective and cross-sectional ultrasound study of the glands in cases with CFs was performed. The sample included users of hyaluronic acid, silicone oil, polymethylmethacrylate, polycaprolactone, calcium hydroxyapatite, and polyacrylamide. | |
dc.description.abstract | Abnormalities of the parenchyma and hypervascularity signs of the glands were compared with a control group (n = 10), evaluated by 2 observers, and correlated with the type, number, and location of the facial CFs. Cohen's kappa test and logistic regression models with odds ratios (OR) adjusted by age with 95% CI were performed. | |
dc.description.abstract | Results Sixty-three patients with CFs met the criteria. Parotid and submandibular glands had the highest percentage of parenchymal involvement: 87.3 and 88.9%, respectively (p <.01). Abnormalities of the echostructure of the parenchyma and hypervascularity of the glands were detected with all kinds of fillers without significant differences per type. A significant substantial interrater kappa (0.61) with an agreement of 90% for all glands among observers was found. | |
dc.description.abstract | Conclusion Users of common types of CFs frequently present subclinical ultrasonographic signs of inflammation of the lacrimal, parotid, and submandibular glands. Further research on the topic seems necessary. | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1002/jum.15621 | |
dc.identifier.eissn | 1550-9613 | |
dc.identifier.issn | 0278-4297 | |
dc.identifier.uri | https://doi.org/10.1002/jum.15621 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/95084 | |
dc.identifier.wosid | WOS:000605752000001 | |
dc.issue.numero | 11 | |
dc.language.iso | en | |
dc.pagina.final | 2389 | |
dc.pagina.inicio | 2377 | |
dc.revista | Journal of ultrasound in medicine | |
dc.rights | acceso restringido | |
dc.subject | cosmetic fillers ultrasound | |
dc.subject | dermatologic ultrasound | |
dc.subject | fillers ultrasound | |
dc.subject | lacrimal gland ultrasound | |
dc.subject | parotid gland ultrasound | |
dc.subject | salivary glands ultrasound | |
dc.subject | submandibular gland ultrasound | |
dc.subject | ultrasound | |
dc.subject.ods | 05 Gender Equality | |
dc.subject.odspa | 05 Igualdad de género | |
dc.title | Ultrasonographic subclinical signs of inflammation of the lacrimal, parotid, and submandibular glands in users of cosmetic fillers | |
dc.type | artículo | |
dc.volumen | 40 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |